Content
09/05/2024
Los Gatos, CA USA
Venova Medical
completed $30 million Series B Round funding. Investors include
Aphelion Capital, Cadence Healthcare Ventures, Catalyst Health Ventures, Mirae Asset Capital, ShangBay Capital.
About
Despite clear benefits of initiating hemodialysis with an arteriovenous fistula--including lower mortality, less reinterventions and lower health care costs—few patients in the US do so. Venova Medical is developing the next generation of vascular access systems that will address patient level and system barriers for access creation while simultaneously providing quickly functioning access with less need for reintervention.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
